REPLACE-2 Investigators. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial - Lincoff, AM; Bittl, JA; Harrington, RA (J Am Med Assoc, 2003)
et al.